학술논문

Structure-based discovery of opioid analgesics with reduced side effects
Document Type
Report
Source
Nature. September 8, 2016, Vol. 537 Issue 7619, p185, 6 p.
Subject
Bioavailability -- Genetic aspects -- Research
Pharmaceutical research
Drug metabolism -- Research -- Genetic aspects
Opioids -- Genetic aspects -- Research
Environmental issues
Science and technology
Zoology and wildlife conservation
Language
English
ISSN
0028-0836
Abstract
Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side effects of morphine and related opioidswhich include fatal respiratory depressionare thought to be mediated by -opioid-receptor (OR) signalling through the -arrestin pathway or by actions at other receptors. Conversely, G-protein OR signalling is thought to confer analgesia. Here we computationally dock over 3 million molecules against the OR structure and identify new scaffolds unrelated to known opioids. Structure-based optimization yields PZM21a potent G[sub.i] activator with exceptional selectivity for OR and minimal -arrestin-2 recruitment. Unlike morphine, PZM21 is more efficacious for the affective component of analgesia versus the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. PZM21 thus serves as both a probe to disentangle OR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.
Author(s): Aashish Manglik [1]; Henry Lin [2]; Dipendra K. Aryal [3]; John D. McCorvy [3]; Daniela Dengler [4]; Gregory Corder [5]; Anat Levit [2]; Ralf C. Kling [4, 6]; Viachaslau [...]